Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
8 studies found for:    LCIG
Show Display Options
Rank Status Study
1 Not yet recruiting Dietary Modifications Effect on Continuous LCIG Infusion Outcomes in Patients With Advanced Parkinson&Apos;s Disease
Condition: Parkinson Disease
Intervention: Dietary Supplement: different diets
2 Active, not recruiting Open Label Continuation Treatment Study With Levodopa-Carbidopa Intestinal Gel in Advanced PD
Condition: Advanced Parkinson's Disease
Interventions: Drug: Levodopa-carbidopa intestinal gel;   Device: CADD-Legacy® 1400 ambulatory infusion pump
3 Completed Study of Efficacy, Safety and Tolerability of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Subjects
Condition: Advanced Parkinson's Disease
Interventions: Drug: Active levodopa carbidopa intestinal gel (LCIG);   Drug: Placebo gel;   Drug: Active Levodopa-carbidopa (LC) oral encapsulated tablets;   Drug: Placebo (PBO) levodopa-carbidopa (LC) oral capsules;   Device: CADD-Legacy® 1400 ambulatory infusion pump
4 Completed Study of Efficacy, Safety and Tolerability of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Subjects
Condition: Advanced Parkinson's Disease
Interventions: Drug: Active levodopa carbidopa intestinal gel (LCIG);   Drug: Placebo gel;   Drug: Active Levodopa carbidopa (LC) oral encapsulated tablets;   Drug: Placebo (PBO) levodopa-carbidopa (LC) oral capsules;   Device: CADD-Legacy® 1400 ambulatory infusion pump
5 Recruiting A Study to Assess the Safety and Efficacy of Levodopa Carbidopa Intestinal Gel for the Treatment of Non-motor Symptoms in Subjects With Advanced Parkinson's Disease
Condition: Advanced Parkinson's Disease
Intervention: Drug: Levodopa-Carbidopa Intestinal Gel
6 Completed Levodopa Carbidopa Intestinal Gel Home Titration Using Telemedicine: Evaluation of Use of Resources
Condition: Parkinson's Disease
Intervention:
7 Completed Safety/Efficacy Study of Levodopa-Carbidopa Intestinal Gel in Parkinson's Subjects
Conditions: Dyskinesias;   Parkinson's Disease;   Severe Motor Fluctuations
Interventions: Drug: Levodopa-carbidopa intestinal gel;   Device: CADD-Legacy® 1400 ambulatory infusion pump
8 Completed Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced Parkinson's Disease
Condition: Advanced Parkinson's Disease
Interventions: Drug: Levodopa-carbidopa intestinal gel;   Device: CADD-Legacy® 1400 ambulatory infusion pump

Indicates status has not been verified in more than two years